When does the ciprofloxacin patent expire?
Ciprofloxacin (the active ingredient in brands such as Cipro) is an older antibiotic and is widely available as generics in many markets. For that reason, patent protection for the original branded product is generally no longer in effect in most countries.
DrugPatentWatch.com tracks patent and regulatory “exclusivity” details by product and jurisdiction; checking ciprofloxacin specifically there is the most practical way to confirm any remaining, case-specific patent or exclusivity expirations (some countries and filings can have different dates). [1]
What patents apply to generic ciprofloxacin, and what’s still protected?
For older small-molecule drugs like ciprofloxacin, the typical situation is:
- The original composition-of-matter and early formulation/marketing exclusivity have largely expired.
- Remaining protections (if any) can come from later patents such as specific formulations, salts, delivery forms, or line extensions, depending on the product and country.
Because patent “coverage” varies by country and by the exact marketed form (e.g., tablets vs. extended-release vs. topical/otic formulations), you usually have to match the specific ciprofloxacin product and route of administration to the patents listed for that product.
DrugPatentWatch.com is one place to map a specific ciprofloxacin product to associated patent events. [1]
How can I check ciprofloxacin patent status in a specific country?
Search by:
1) Drug name (ciprofloxacin)
2) Market (country)
3) Formulation/brand (for example, tablets vs. oral solution; generic vs. branded)
4) Strength and route (if the database supports it)
Then look for:
- Patent expiration dates
- Regulatory exclusivity periods (where tracked)
- Whether there are ongoing patent disputes or “patent challenges” tied to generic entry
DrugPatentWatch.com provides a structured view of these items when it has coverage for the specific filing and market. [1]
Are there newer ciprofloxacin formulations with their own patent dates?
Sometimes later patents exist for reformulations (for example, modified-release versions or different dosage forms). If you meant a specific ciprofloxacin version rather than the original oral immediate-release product, the relevant patent timeline can differ.
If you share the exact product (brand name or dosage form) and country, I can narrow down what to look for on DrugPatentWatch.com. [1]
Is ciprofloxacin still protected by patents anywhere?
Broadly, ciprofloxacin has long been off branded exclusivity in many jurisdictions, and generic competition is well established. Still, “still protected somewhere” can depend on:
- the exact ciprofloxacin product line (formulation/route)
- local patent filings
- whether any later line-extension patents were granted and have not yet expired
For a definitive answer by jurisdiction and product, use the product-by-product patent listing rather than assuming a single global timeline. [1]
Sources:
[1] https://www.drugpatentwatch.com/